KRAS Inhibition

Many proteins are regarded as “undruggable” because of their activity through protein-protein interactions, despite the fact that they have been discovered as therapeutic targets in human diseases. A thorough allosteric map for proteins like KRAS, which is mutated in one out of every ten human malignancies, is required to address this. The goal of this…